tiprankstipranks
Trending News
More News >
Premier Inc (PINC)
:PINC

Premier (PINC) AI Stock Analysis

Compare
166 Followers

Top Page

PI

Premier

(NASDAQ:PINC)

Rating:76Outperform
Price Target:
$26.00
▲(15.20%Upside)
Premier's overall stock score of 76 reflects a mix of strong technical momentum and positive strategic initiatives, despite challenges in financial performance. The company's efforts to enhance shareholder value through stock repurchase programs and strategic partnerships bolster investor confidence. However, high valuation and operational challenges remain areas to watch.
Positive Factors
Contract Negotiations
Member fee share renegotiations are progressing faster than anticipated, with over 75% of negotiations completed by the end of 3Q and over 80% expected to be completed by the end of the fiscal year.
Earnings
Premier reported a F3Q beat and lifted FY25 Adj EBITDA guidance modestly.
Shareholder Returns
PINC rewards shareholders with a 3.7% dividend yield and another $200M share repurchase under its $1B authorization.
Negative Factors
Fee Pressure
Net GPO admin fee revenue declined 10% y/y as the negotiated increases in the share to its hospital members more than offset growth in gross admin fee revenue.
Performance Services
Performance Services results were an area of weakness in the quarter, with lower guidance also showing the challenges in the business currently.
Revenue Decline
Net revenue declined 8% y/y and rose 10% q/q to $255M (ex Contigo Health which will be fully divested by year end).

Premier (PINC) vs. SPDR S&P 500 ETF (SPY)

Premier Business Overview & Revenue Model

Company DescriptionPremier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; STOCKD, an e-commerce platform; PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company also provides services to other businesses, including food service, schools, and universities. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
How the Company Makes MoneyPremier, Inc. generates revenue primarily through its group purchasing organization (GPO) and performance services. The GPO aggregates purchasing volume from member hospitals and healthcare providers to negotiate discounts with manufacturers, earning fees based on the volume of products purchased. Additionally, the company offers supply chain co-management solutions that contribute to its revenue. In the Performance Services segment, Premier provides subscription-based data analytics and consulting services that help healthcare providers enhance quality, safety, and cost management, further adding to its earnings. Strategic partnerships, alliances, and technology-driven solutions also play a crucial role in the company's revenue generation.

Premier Earnings Call Summary

Earnings Call Date:May 06, 2025
(Q3-2025)
|
% Change Since: 11.07%|
Next Earnings Date:Aug 19, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mix of strong sequential growth and strategic advancements, such as the partnership with Epic and an accelerated share repurchase program, which were positively received. However, challenges persist with consulting revenue decline and tariff concerns affecting healthcare providers' operational environment.
Q3-2025 Updates
Positive Updates
Strong Sequential Revenue Growth
Net revenue of $261 million for the third quarter grew $21 million sequentially compared to Q2. Adjusted EBITDA excluding Contigo Health was $73 million, representing a sequential improvement of $21 million, achieving the highest quarterly margin of this fiscal year at 28.4%.
Accelerated Share Repurchase Program
Premier initiated a $200 million accelerated share repurchase program during the quarter, resulting in the receipt of 9 million shares, with expectations for final settlement by fiscal Q1 2026.
Supply Chain Services Performance
The Supply Chain Services segment performed above expectations, with gross administrative fees growing 3.5% over the prior year period, driven by higher contract penetration and onboarding new members.
Strategic Partnership with Epic
Premier announced a strategic partnership with Epic, aiming to launch a documentation and coding solution by late 2025, expanding Premier's reach to Epic's vast customer base.
Dividend Declaration
Premier's Board declared a dividend of $0.21 per share payable in June, with a total of $60 million returned in dividends in the first nine months of fiscal year 2025.
Negative Updates
Decline in Consulting Revenue
The Performance Services segment experienced lower consulting revenue compared to the prior year period, although partially offset by better performance in the applied sciences business.
Impact of Tariffs on Healthcare Providers
Tariffs remain a concern, potentially impacting care delivery. Premier is actively monitoring developments and advocating in Washington, but the situation remains fluid and requires continued monitoring.
Challenge in Contract Renewals
Net revenue declined by $25 million from the prior year period, largely driven by higher fee share from contract renewals, which is mostly completed but still impacting financial results.
Company Guidance
During Premier's fiscal year 2025 third quarter conference call, the company reported strong results with significant sequential growth in revenue, adjusted EBITDA, and adjusted EPS, surpassing expectations. The Supply Chain Services segment, in particular, contributed to this performance, prompting Premier to increase its full-year guidance for adjusted EBITDA and adjusted EPS, while reaffirming the midpoint of its consolidated revenue guidance. Premier's efforts to enhance supply chain resilience, member-driven contracting strategies, and investments in technology and advisory services were highlighted as key factors driving this success. The company also initiated a $200 million accelerated share repurchase program and continued its quarterly cash dividend, reflecting a commitment to returning value to stockholders. Additionally, Premier is actively addressing challenges like tariffs and workforce shortages, leveraging data and AI-enabled solutions to support healthcare providers in delivering high-quality, affordable care.

Premier Financial Statement Overview

Summary
Premier's financials reveal a stable yet challenged performance. While strong operational efficiency and prudent financial management are evident, declining revenues and net margins suggest pressure in market dynamics. Continuous focus on cash flow improvements and cost management will be crucial to sustain financial health.
Income Statement
65
Positive
The company's revenue has shown fluctuations, with a notable decline from 2021 to 2025. The gross profit margin has remained relatively stable around 60-65%, indicating efficient production management. However, the net profit margin has decreased over the years, reflecting higher costs or reduced pricing power. The TTM data shows a concerning drop in net income, suggesting potential financial pressures.
Balance Sheet
70
Positive
Premier has maintained a strong equity position, with the equity ratio improving from 2020 to 2025. The debt-to-equity ratio has fluctuated but remains manageable, indicating prudent financial leverage. The reduction in cash and cash equivalents could pose liquidity risks, but overall, the balance sheet is solid with a consistent increase in stockholders' equity.
Cash Flow
75
Positive
The company has demonstrated strong free cash flow generation, with a positive growth trajectory. Operating cash flow consistently exceeds net income, which is a positive indicator of cash-generating efficiency. However, the decline in free cash flow in TTM suggests caution for future cash management.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
1.10B1.35B1.34B1.43B1.72B1.30B
Gross Profit
770.82M888.01M896.29M885.04M837.33M866.80M
EBIT
78.91M127.97M242.09M260.07M256.92M373.62M
EBITDA
189.51M256.97M398.26M467.15M383.67M547.83M
Net Income Common Stockholders
62.51M119.54M175.03M265.87M287.52M291.13M
Balance SheetCash, Cash Equivalents and Short-Term Investments
71.33M125.15M89.79M86.14M129.14M99.30M
Total Assets
3.07B3.40B3.37B3.36B3.52B2.95B
Total Debt
283.32M113.70M440.33M487.29M521.67M137.19M
Net Debt
211.99M-11.45M350.54M401.14M392.53M37.89M
Total Liabilities
1.55B1.44B1.04B1.11B1.29B2.81B
Stockholders Equity
1.52B1.96B2.33B2.25B2.23B139.26M
Cash FlowFree Cash Flow
325.27M215.37M362.24M356.79M318.53M255.13M
Operating Cash Flow
399.73M296.56M444.54M444.23M407.40M349.52M
Investing Cash Flow
-54.06M-68.47M-273.62M-139.44M-174.57M-222.32M
Financing Cash Flow
-336.13M-192.72M-167.27M-347.79M-203.00M-168.95M

Premier Technical Analysis

Technical Analysis Sentiment
Positive
Last Price22.57
Price Trends
50DMA
21.38
Positive
100DMA
20.17
Positive
200DMA
20.30
Positive
Market Momentum
MACD
0.32
Positive
RSI
53.67
Neutral
STOCH
18.57
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PINC, the sentiment is Positive. The current price of 22.57 is below the 20-day moving average (MA) of 22.87, above the 50-day MA of 21.38, and above the 200-day MA of 20.30, indicating a neutral trend. The MACD of 0.32 indicates Positive momentum. The RSI at 53.67 is Neutral, neither overbought nor oversold. The STOCH value of 18.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PINC.

Premier Risk Analysis

Premier disclosed 45 risk factors in its most recent earnings report. Premier reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Premier Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$1.86B39.536.05%3.72%-17.69%-10.24%
67
Neutral
$1.37B64.371.73%3.00%
67
Neutral
$1.56B58.824.43%4.35%
DHDH
57
Neutral
$534.14M-86.36%-3.04%-152.59%
55
Neutral
$191.81M-60.75%4.66%11.33%
EVEVH
54
Neutral
$970.90M-10.99%10.24%2.63%
54
Neutral
$5.38B3.27-45.10%3.30%16.81%0.02%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PINC
Premier
22.57
5.19
29.86%
OMCL
Omnicell
29.25
1.34
4.80%
EVH
Evolent Health
8.27
-13.40
-61.84%
GDRX
GoodRx Holdings
4.37
-4.02
-47.91%
SOPH
SOPHiA GENETICS
2.87
-2.08
-42.02%
DH
Definitive Healthcare Corp
3.65
-1.92
-34.47%

Premier Corporate Events

Stock BuybackFinancial Disclosures
Premier Reports Q3 2025 Financial Results Improvement
Positive
May 7, 2025

On May 6, 2025, Premier, Inc. announced its financial results for the third quarter of fiscal year 2025, which ended on March 31, 2025. The company reported a total net revenue of $261.4 million, a 9% decrease from the previous year but a 9% increase from the previous quarter. Net income from continuing operations was $27.6 million, a significant improvement from a net loss in the same period last year. Despite a decrease in adjusted EBITDA and EPS compared to the prior year, both metrics showed substantial growth from the second quarter of fiscal 2025. The company attributed its sequential revenue and profitability growth to better-than-expected performance in its Supply Chain Services segment. Premier also increased its adjusted EBITDA and EPS guidance while reaffirming its revenue guidance midpoint, highlighting the positive impact of its share repurchase program.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.